Dear Sir/Madam, Please find the attached proceedings of 23rd Annual General Meeting held on 30th September, 2025. Thanking You.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Limited held its 23rd Annual General Meeting on 30th September 2025 via video conferencing, from 11:30 AM to 11:40 AM. The meeting, chaired by Wholetime Director Mrs. Sakshi Laller, had 4,371 shareholders on record as of 23rd September 2025. Four resolutions were transacted: (1) adoption of audited financial statements for FY ending 31 March 2025, (2) re-appointment of Mrs. Sakshi Laller as director (retiring by rotation), (3) ratification of M/s. Garg Mendiratta and Associates as new statutory auditors following the resignation of M/s. Harjeet Parvesh and Company, and (4) approval of related party transactions. E-voting ran from 27th to 29th September 2025, and no shareholder queries were raised during the meeting. Voting results will be communicated to the exchanges after receipt of the Scrutiniser's report.
The change of statutory auditor (from Harjeet Parvesh to Garg Mendiratta due to a casual vacancy) is a notable governance event shareholders should track. Approval of related party transactions also warrants investor attention, as these can affect minority shareholder interests. Overall, the meeting was brief with routine business and no shareholder dissent or questions raised.